Eporise Inj

Composition: Each vial (pre-filled syringe) contains: Recombinant Human Erythropoientin (r-Hu-EPO) 2000/4000/10,000/20,000/40,000 IU.

Indications: Anemia of chronic renal failure patients, zidovudine-treated HIV-infected patients, cancer patients on chemotherapy; reduction of allogeneic red blood cell transfusions in patients undergoing elective, non-cardiac, non vascular surgery.

Contraindications: Uncontrolled hypertension, pure red cell aplasia, hypersensitivity to mammalian-derived products or albumin.

Precautions: Caution advised in patients with coexistent cardiovascular disease and stroke; blood pressure should be controlled in hypertensive patients before initiation of therapy; adjustments to dialysis prescriptions may be required after initiation of therapy.

Adverse Effects: Constipation, diarrhea, indigestion, nausea, vomiting, fever, anxiety.

Dosage and administration: As per physician’s discretion based on the indication. (For detailed information please write to Zuventus Healthcare Limited, 5119, 5th floor, D-Wing, Oberoi Garden Estates, Chandivali, Andheri (E), Mumbai 400 072 or email to medico@zuventus.com).